An analysis by Blue Cross Blue Shield found that even though only 18% of total prescriptions filled were for expensive branded drugs, they accounted for 78% of total spending since 2010. The biggest costs came from Humira, Remicade and Enbrel.
Expensive brand-name medications lead drug spending
Sign up for BIO SmartBrief
Biotechnology industry news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.